Document:

ex10-1.htm

Exhibit 10.1

AMENDMENT NO. 2

TO

AMENDED AND RESTATED

NOTE CONVERSION AGREEMENT

AND

WARRANT AMENDMENT

 

THIS AMENDMENT NO. 2 TO AMENDED AND RESTATED NOTE CONVERSION AGREEMENT AND WARRANT AMENDMENT (this “Agreement”) is entered into on September 30, 2014, by and between VistaGen Therapeutics, Inc., a Nevada corporation (the “Company”), and Platinum Long Term Growth VII, LLC, a Delaware limited liability company (“Platinum”).

 

WHEREAS, the parties entered into an Amended and Restated Note Conversion Agreement and Warrant Amendment on July 18, 2014 (“Amendment”), which Amendment amends and restates that certain Note Conversion Agreement, dated April 4, 2013, and amends certain warrants issued to Platinum prior to the date of the Amendment, each as more particularly set forth in the Amendment; and

WHEREAS, the parties further amended the Amendment pursuant to Amendment No. 1 to Amended and Restated Note Conversion Agreement and Warrant Amendment, dated September 2, 2014 (“Amendment No. 1”), pursuant to which the parties agreed to extend the date upon which the Company is able to consummate a Qualified Financing, as such term is defined in the Amendment, to September 30, 2014;

WHEREAS, the parties agree to amend the Amendment, as amended by Amendment No. 1, as more particularly set forth below, in order to further extend the date upon which the Company is able to consummate a Qualified Financing, as such term is defined in the Amendment.

 NOW, THEREFORE, for and in consideration of the mutual agreements set forth herein, the parties hereto agree as follows:

 

1.            The definition of “Closing Date”, as such term is defined in Section 1 of the Amendment, shall be revised to October 31, 2014, and each reference to August 31, 2014 in the Amendment shall be amended and replaced with October 31, 2014.

2.           The provisions of the Amendment, as modified herein, shall remain in full force and effect in accordance with its terms and are hereby ratified and confirmed.  Platinum does not in any way waive the Company’s obligations to comply with any of the provisions, covenants and terms of the Amendment (as amended hereby) and the other agreements referred to in the Amendment.  This Agreement shall be governed by the laws of the State of New York without regard to the conflict of laws provisions thereof.

3.           As a result of the execution of this Agreement, the parties agree and acknowledge that Amendment No. 1 shall terminate and be of no further force and effect.

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]

  

  

  

IN WITNESS WHEREOF the parties have signed this instrument as of the date first set forth above.

	
ADDRESS:

	  	  	
VISTAGEN THERAPEUTICS, INC.

	
343 Allerton Avenue

South San Francisco, California 94080

	  	  	  
	  	  	  	
By: /s/ Shawn K. Singh

Name: Shawn K. Singh

Title: Chief Executive Officer

	  	  	  	  
	  	  	  	  
	
ADDRESS:

	  	  	
PLATINUM LONG TERM GROWTH VII, LLC

	
152 West 57th Street, 4th Floor

New York, NY 10019

	  	  	  
	  	  	  	
By: /s/ Mark Nordlicht

Name: Mark Nordlicht

Title: Authorized Signatory

	  	  	  	  

[Signature Page to Amendment No. 2 to Amended and Restated Note Conversion Agreement and Warrant Amendment]FY2015_Q1_8K_Ex10.1_Iger Extension Letter

Exhibit 10.1

October 2, 2014

Mr. Robert Iger
Chief Executive Officer and Chairman
The Walt Disney Company
500 S. Buena Vista Avenue
Burbank, CA

Amendment to Amended and Restated Employment Agreement
Dated as of October 6, 2011, as amended July 1, 2013
This letter amends the above captioned employment agreement (the “Agreement”) to provide that the Employment Period thereof shall be extended so as to end on June 30, 2018.  Except as expressly provided herein, all references in the Agreement to June 30, 2016 shall be changed to June 30, 2018.  Notwithstanding the immediately preceding sentence or anything else in the Agreement, you may elect to voluntarily retire from employment with the Company at any date after June 30, 2016 so long as you shall have provided the Board at least six months’ advance written notice of  termination of your employment.
Your base salary, target annual incentive and target award value under Section 3(b) and 3(c) of the Agreement for fiscal years 2017 and 2018 shall be the same as those that currently apply for fiscal year 2016 and the awards for such years shall be subject to the same terms and conditions as awards to be granted in 2016.  In determining any annual incentive payable under Section 3(b) for fiscal year 2016 or fiscal year 2018, you shall be eligible to receive such incentive if, in either case, you remain employed at least through June 30 of the applicable year.  If you retire in fiscal year 2016, any vesting and, if applicable, exercise periods that would have applied under Section 3(c)(i)(E) or 3(c)(ii)(D) under the original terms of the Agreement to any award granted prior to June 30, 2016 had you remained employed through June 30, 2016 (i.e., the originally scheduled end of the Employment Period) shall continue to apply if you remain employed through June 30, 2016. With respect to any awards made after June 30, 2016, any vesting and, if applicable, exercise period applicable under Section 3(c)(i)(E) or 3(c)(ii)(D) shall only apply if you remain employed through June 30, 2018. The vesting and, if applicable, exercise periods that would have applied in respect of any outstanding equity awards under either Section 5(d) and 5(e) in connection with a Termination Date occurring on or after the date the Chairman Period would have commenced (i.e., April 1, 2015) shall also apply in respect of awards granted after  June 30, 2016. 
As consideration for the extension of the term of the Agreement, you shall be eligible to receive an additional bonus payment (the “Growth Incentive Retention Bonus”) if you are continuously employed with the Company through June 30, 2018 (or your employment terminates under any of the circumstances described in paragraph 4 below), and during the periods specified herein, the Company achieves at least the lowest level of cumulative operating income (“COI”) set forth in the table below (or as the same may be adjusted in accordance with the terms hereof). Any amount of the Growth Incentive Retention Bonus that you earn (the “Earned Award”), including pursuant to paragraph 5 below, shall be paid to you in cash, less required tax withholding, on the later to occur of (i) December 1, 2018 and (ii) your separation from service with the Company; provided, however, that any amount payable on account of your separation 

from service will be payable on the date that is six months after such separation.  If pursuant to the terms of this letter, payment of the Growth Incentive Retention Bonus is deferred to a date that is more than 90 days after the time at which the Earned Award is determined, the Earned Amount shall be deemed invested in a deferred compensation account that shall offer you deemed investment opportunities which are at least the same (except as may be required to comply with Company policies related to insider trading in the Company’s common stock) as the most diverse investment choices available under any other non-qualified deferred compensation arrangement or qualified individual account plan maintained by the Company or any of its affiliates. The terms of the Growth Incentive Retention Bonus are as follows:
1.    “COI” equals aggregate segment operating income as reported in the Company’s financial statements for each of the Company’s five consecutive fiscal years ending with September 29, 2018, which five years are the “Performance Period;” provided, however, that, if the Company's accounting policies or practices change for any reason such that the manner in which aggregate segment operating income is determined for any period subsequent to fiscal year 2014 differs from that applicable in respect of fiscal year 2014 then, for purposes of this Agreement, COI shall be adjusted such that such measure is determined with respect to all relevant periods in the same manner as applied in respect of fiscal year 2014. 
2.     The Earned Award shall be determined based on the following performance schedule:
    	
								
	 
	(1)
	(2)
	(3)
	(4)
	(5)
	(6)
	(7)

	COI
(billions)
	<$76.010
	$76.389
	$76.771
	$77.154
	$77.539
	$77.925
	>$78.314

	Earned
Award
(millions)
	$0
	$10
	$20
	$30
	$40
	$50
	$60

The numbers in the row marked “COI (billions”) shall be referred to herein as the COI Targets. 
3.    The Earned Award with respect to COI at levels between the amounts stated in the above table shall be determined by linear interpolation. For example, COI of $76.9625 billion would result in an Earned Award of $25 million.

4.    If your employment terminates before June 30, 2018 on account of death or  Termination due to a Disability, you shall be entitled to a prorated portion of the Earned Award, if any, that would otherwise be payable had you remained employed through June 30, 2018.  If your employment terminates before June 30, 2018 due to the Company’s exercise of its Termination Right, or a Termination for Good Reason, you shall be entitled to (i) a prorated portion of the Earned Award, if your termination occurs on or prior to the last day of fiscal year 2017, or (ii) the full Earned Award, if your termination occurs after fiscal year 2017, that would otherwise be payable had you remained employed through June 30, 2018. Any pro-rated portion payable shall be determined based on the ratio of (a) the number of days you were employed during the last four fiscal years in the Performance Period to (b) the total number of days in the last four years of the Performance Period through June 30, 2018, which is 1,372.  Payment of any amount in respect of the Growth Incentive Retention Bonus shall not be accelerated due to your termination of employment. 
5.     Notwithstanding paragraphs 2, 3 and 4, in the event that, prior to September 29, 2018, the Company undergoes a “Change in Control,” as defined in the Amended and Restated 2011 Stock Incentive Plan, (i) on or before the last day of fiscal year 2016, the Earned Award shall be zero or (ii) after fiscal year 2016, the Earned Award shall be determined as of the date of the Change in Control, by measuring against the COI Targets the sum of (i) the aggregate adjusted operating income earned during the Performance Period through the fiscal quarter ending coincident with or immediately prior to the Change in Control (the “Last Ended Fiscal Quarter”) and (ii) the adjusted operating income that would have been earned during the remaining fiscal quarters during the Performance Period (the “Remaining Quarters”), determined as provided below.  First, the compound annual growth rate in adjusted operating income achieved from the beginning of the Performance Period to the Last Ended Fiscal Quarter (the “Annual Growth Rate”) shall be calculated.  The Annual Growth Rate shall then be used to calculate a quarterly growth rate )the “Quarterly Growth Rate”) and the amount of adjusted operating income deemed earned for the first quarter ending following the Change in Control (the “Initial Quarterly AOI”), such that by applying the Quarterly Growth Rate over a period of four quarters and starting with the Initial Quarterly AOI, the deemed adjusted operating income would achieve the same aggregate result as by applying the Annual Growth Rate over the same period (the “Quarterly Growth Rate”) to the actual adjusted operating income accrued for the four quarters ending with the Last Ended Fiscal Quarter.  The deemed adjusted operating income for each other Remaining Quarter after the first such Remaining Quarter shall be determined assuming that, in each such Remaining Quarter, the Initial  Quarterly AOI, as adjusted to reflect the assumed growth at the Quarterly Growth Rate in each Remaining Quarter that would have previously preceded in chronological order, grew at the Quarterly Growth Rate.   In order to receive any Earned Award payable in the event of a Change in Control, you must remain employed through June 30, 2018 or, if your employment terminates as of an earlier date, it must terminate due to one of the circumstances described in paragraph 4. Payment of any Earned Award shall be made at the time specified above 
6.    If the Company or one of its affiliates whose income is consolidated with the 

Company for financial accounting purposes (a “Consolidated Entity”) shall (i) divest or otherwise transfer any subsidiary or other business unit or division to any person other than a Consolidated Entity (including any distribution of assets to the Company’s shareholders) or (ii) purchase or otherwise acquire any subsidiary or other business unit or division, and the Board or the appropriate Committee thereof determines in good faith that an adjustment to the COI Targets is necessary or appropriate to prevent either (A) an enhancement of, or diminution in, the opportunity provided by the Growth Incentive Retention Bonus or (B) an unintended incentive or disincentive in regard to the operations of the Company or a specified segment thereof,  such COI Targets shall be adjusted in such manner and to such extent the Board or the applicable Committee considers fair, reasonable and equitable under the circumstances.  Notwithstanding the immediately preceding sentence, no adjustment shall made in respect of any such divestiture or acquisition if the aggregate amount being received or paid by a Consolidated Entity for such assets is less than $250 million, unless you shall request that the Board or the applicable Committee consider, and the Board or such Committee determines to make, an appropriate adjustment to the COI Targets in respect of such divestiture or acquisition.  
Except as specified above, the Agreement shall otherwise continue in accordance with its terms. Defined terms used, but not defined, in this letter have the meanings ascribed thereto in the Agreement.  If you agree that the foregoing sets forth our full understanding regarding the amendment of the Agreement, please evidence your agreement and acceptance by counter-signing two copies of this letter where indicated below, returning one executed copy to me.
	
				
	 

	 
	 
	 
	 

	THE WALT DISNEY COMPANY

	 
	 
	 

	By:
	 
	/s/ Alan N. Braverman
	 

	 
	 
	 Alan N. Braverman
	 

	 
	 
	Senior Executive Vice President,
	 

	 
	 
	General Counsel and Secretary
	 

	
				
	 

	 
	 
	 
	 

	AGREED AND ACCEPTED:

	 
	 
	 

	/s/ Robert A. Iger
	 

	Robert A. Iger
	 

	Date:
	 
	10/2/2014

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00236-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00236-of-00352.parquet"}]]